2024 Japan Respiratory Disease Molecular Diagnostics Market Shares: and Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

August 2024 | - | ID: 27D046FBE9E5EN
Venture Planning Group

Abstracts

About This Report This new 282-page report from LeadingMarketResearch.com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. ;   In addition to market share and sales forecasts, the report:-  Examines market applications of Molecular Diagnostics, ; 
  & Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; -  Reviews features and operating characteristics of major analyzers used ;
  & for microbiology testing; -  Profiles key suppliers and potential market entrants developing innovative
  & technologies and products; and -  Analyzes emerging opportunities, alternative market penetration strategies, ;
  & market entry barriers/risks, and strategic planning issues.Methodology The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch's proprietary data files was conducted.Contains 282 pages and 24 tables

Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests

1. ADENOVIRUS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)

2. CORONAVIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

3. INFLUENZA VIRUSES

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

4. LEGIONELLA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

5. MONONUCLEOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

6. MYCOPLASMA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

7. PNEUMONIA

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

8. RESPIRATORY SYNCYTIAL VIRUS (RSV)

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

9. TUBERCULOSIS

a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies

1. MOLECULAR DIAGNOSTICS

2. MONOCLONAL ANTIBODIES

3. IMMUNOASSAYS

4. DIFFERENTIAL LIGHT SCATTERING

5. INFORMATION TECHNOLOGY

6. ARTIFICIAL INTELLIGENCE

7. LIPOSOMES

8. FLOW CYTOMETRY

9. CHROMATOGRAPHY

10. DIAGNOSTIC IMAGING

11. GEL MICRODROPLETS

12. OTHER

III. Country Analysis: Market Size, Growth and Major
Suppliers’ Sales and Market Shares
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets

1. MARKETING APPROACHES

2. PRODUCT COMPLEXITY

3. CUSTOMER PREFERENCE